Moderna

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. 

CEO
Stéphane Bancel
CEOStéphane Bancel
Employees
4,700
Employees4,700
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2010
Founded2010
Employees
4,700
Employees4,700

MRNA Key Statistics

Market cap
75.82B
Market cap75.82B
Price-Earnings ratio
-23.80
Price-Earnings ratio-23.80
Dividend yield
—
Dividend yield—
Average volume
16.63M
Average volume16.63M
High today
$193.72
High today$193.72
Low today
$183.28
Low today$183.28
Open price
$190.20
Open price$190.20
Volume
10.29M
Volume10.29M
52 Week high
$208.90
52 Week high$208.90
52 Week low
$22.28
52 Week low$22.28

Stock Snapshot

As of today, Moderna(MRNA) shares are valued at $189.64. The company's market cap stands at 75.82B, with a P/E ratio of -23.80.

As of 2026-10-03, Moderna(MRNA) stock has fluctuated between $183.28 and $193.72. The current price stands at $189.64, placing the stock +3.5% above today's low and -2.1% off the high.

The Moderna(MRNA)'s current trading volume is 10.29M, compared to an average daily volume of 16.63M.

During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $208.90 at its peak.

During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $208.90 at its peak.

MRNA News

Simply Wall St 15h
Moderna Stock Looks Too Expensive For Its Sales Story

has seen its share price move sharply over the past year, helped by fresh headlines and shifting expectations for its pipeline. That kind of run naturally raise...

Moderna Stock Looks Too Expensive For Its Sales Story
Investing.com 1d
Why is Moderna stock rallying today? - Investing.com

...

Why is Moderna stock rallying today? - Investing.com
TipRanks 2d
Why Did Moderna Stock Gain in After-Hours Trading on Thursday?

Moderna (MRNA) stock inched higher by 0.16% in after-hours trading on Thursday after falling 1.89% during the regular session. The move came after Nasdaq announ...

Analyst ratings

59%

of 27 ratings
Buy
22.2%
Hold
59.3%
Sell
18.5%

More MRNA News

TipRanks 2d
Moderna to join Nasdaq-100 Index

Nasdaq announced that Moderna (MRNA) will become a component of the Nasdaq-100 Index replacing Warner Bros. Discovery, Inc. (WBD) prior to market open on Friday...

Zacks 2d
Moderna Stock Dips While Market Gains: Key Facts

In the latest trading session, Moderna (MRNA Quick QuoteMRNA - Free Report) closed at $188.94, marking a -1.89% move from the previous day. The stock trai...

Moderna Stock Dips While Market Gains: Key Facts
TipRanks 2d
Cboe data shows mixed options sentiment in Moderna with shares up 1.04%

Cboe data shows mixed options sentiment in Moderna (MRNA), with shares up $2.01, or 1.04%, near $194.58. Options volume roughly in line with average with 65k co...

Benzinga 2d
Moderna Stock Is Trending: What's Going On?

Moderna Inc (NASDAQ:MRNA) shares are trending Thursday as the stock continues working through volatility following a bearish Citi downgrade earlier this week....

Moderna Stock Is Trending: What's Going On?
Investor's Business Daily 2d
After Moderna's 'Outsized Run,' It May Be Time For This Bearish Move

Options After Moderna's 'Outsized Run,' It May Be Time For This Bearish Move Licensing Moderna (MRNA) stock fell more than 5% Wednesday as Citi analyst Geoff Me...

After Moderna's 'Outsized Run,' It May Be Time For This Bearish Move
24/7 Wall St. 2d
Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water

Investing Moderna Climbs 3% Despite Citigroup’s Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water Buyers are stepping into Moderna (NASDAQ:MRNA | M...

Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water
Simply Wall St 2d
Moderna Stock Gets Sell Call As Oncology Hopes Face Valuation Test

Moderna appointed former executive Juan Andres as Chief Operating Officer in early October 2026, a new role focused on scaling manufacturing and execution as th...

Moderna Stock Gets Sell Call As Oncology Hopes Face Valuation Test

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.